ongoing

The COVID CommUNITY – First Nations study is being conducted to understand the immune response and safety of the COVID-19 vaccine in First Nations people who have been disproportionately affected by the pandemic, and have worse outcomes from COVID-19 infection compared to other groups.

The study also aims to understand why some people are not as confident in the COVID-19 vaccine as others, and to document the overall impact of COVID-19 in these communities. The study will also provide insight into how a pandemic of this scale can be prevented in these communities and other vulnerable populations.

Participants for the study are being recruited from First Nations communities:
i From vaccination or assessment centres and;
ii By re-contacting participants (18+) from our on-going prospective cohort studies via telephone/email.
Dried blood spots for assessment of antibodies to COVID vaccination are being assessed from all participants.

Lori Davis Hill

Other investigators on this study include:

  • Six Nations of the Grand River’s Lori Davis Hill, A. Darlene Davis and Sara Smith
  • McMaster University’s Dawn Bowdish (immunology), Mark Loeb (infectious diseases), Gita Wahi (pediatrics) and Sujane Kandasamy (qualitative research)
Study Type

Observational

Study Design

Prospective cohort

NO. of Countries

1

NO. of Sites

3

NO. of Participants

3000

Study Period

2021-2022

Sponsor

PHRI

Back To Top